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Background: Perinatal asphyxia and exposure to intrauterine infection are associated with impaired
neurodevelopment in preterm infants. Acute exposure to non-injurious infection and/or inflammation can either
protect or sensitize the brain to subsequent hypoxia-ischemia. However, the effects of subacute infection and/or
inflammation are unclear. In this study we tested the hypothesis that acute-on-chronic exposure to lipopolysaccharide
(LPS) would exacerbate white matter injury after subsequent asphyxia in preterm fetal sheep.
Methods: Fetal sheep at 0.7 gestational age received a continuous LPS infusion at 100 ng/kg for 24 hours, then
250 ng/kg/24 hours for 96 hours, plus 1 μg boluses of LPS at 48, 72, and 96 hours or the same volume of saline. Four
hours after the last bolus, complete umbilical cord occlusion or sham occlusion was induced for 15 minutes. Sheep
were sacrificed 10 days after the start of infusions.
Results: LPS exposure was associated with induction of microglia and astrocytes and loss of total and immature and
mature oligodendrocytes (n = 9) compared to sham controls (n = 9). Umbilical cord occlusion with saline infusions was
associated with induction of microglia, astrogliosis, and loss of immature and mature oligodendrocytes (n = 9). LPS
exposure before asphyxia (n = 8) was associated with significantly reduced microglial activation and astrogliosis and
improved numbers of immature and mature oligodendrocytes compared to either LPS exposure or asphyxia alone.
Conclusions: Contrary to our initial hypothesis, the combination of acute-on-chronic LPS with subsequent asphyxia
reduced neuroinflammation and white matter injury compared with either intervention alone.
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Preterm birth occurs in 5 to 10% of all live births and is
associated with considerable risk of longterm neurodeve-
lopmental disability [1]. The precise causes of longterm
maldevelopment are controversial, but there is increas-
ing evidence that diffuse injury in the white matter tracts
is associated with astrocytosis and maturational arrest of
oligodendrocytes at postmortem, and longterm neuro-
behavioral disturbances and intellectual disabilities [2,3].
Exposure to perinatal hypoxia-ischemia (HI) or infection
and/or inflammation are both associated with adverse* Correspondence: aj.gunn@auckland.ac.nz
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article, unless otherwise stated.neural outcomes in preterm infants [4-7], and there is
highly suggestive evidence that the combination of infec-
tion and/or inflammation and HI may be particularly
deleterious [8].
There is strong evidence in neonatal rodents that an
injection of a non-damaging dose of gram negative lipo-
polysaccharide (LPS) given either within 6 hours or more
than 72 hours before HI can dramatically increase white
and gray matter injury [9-13]. In contrast, an injection of
LPS at intermediate times, such as 24 hours before HI,
reduced subsequent neural injury (preconditioned the
brain) [12,14,15]. There is evidence that dose as well as
timing is important, since whereas low-dose LPS reduced
damage from subsequent HI 24 hours later, higher
dose LPS (0.3 mg/kg) was associated with increasedCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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available in large animals. In preterm fetal sheep, high-
dose LPS (50 μg/kg) given one hour before occlusion of
the maternal aorta for two minutes impaired circulatory
centralization and cerebral oxygen delivery, with in-
creased mortality [16]. It is striking though, that these
studies have all involved single boluses of LPS. In modern
neonatal care, subclinical infection is more common than
acute severe sepsis and yet is also associated with adverse
outcomes [5,6].
We have recently reported that in preterm fetal sheep
48 hours exposure to a low-dose chronic infusion of
LPS, that did not cause any hemodynamic disturbance,
before three boluses of high-dose LPS 24 hours apart
significantly reduced mortality and attenuated the nadir
of hypotension after the LPS boluses [17,18]. This para-
digm of acute-on-chronic LPS was associated with a fetal
inflammatory response and white matter injury. The
effect of such ongoing exposure to infection on the sus-
ceptibility of the immature brain to subsequent HI is
unknown.
In this study, we tested the hypothesis that acute-on-
chronic inflammation would sensitize the developing
brain to a subsequent period of asphyxia [19], induced
by 15 minutes of umbilical cord occlusion in preterm
fetal sheep at 0.7 gestational age. This duration of as-
phyxia is associated with moderate neural injury [19]
and was chosen to allow scope to show modulation of
injury by LPS. In view of the evidence discussed above
that a four-hour delay after acute LPS exposure typically
increases HI injury in neonatal animals [12], asphyxia
was induced four hours after the last bolus of high-dose
LPS. We have previously shown that a similar paradigm
of acute-on-chronic LPS exposure was associated with
more rapid chemoreflex adaptation to umbilical cord oc-
clusion and did not compromise fetal hemodynamic
adaptation [18]. The neural maturation of 0.7 ga fetal
sheep is broadly equivalent to between 28 and 32 weeks
of human development [20].
Methods
Animal surgery
We have previously reported the cardiovascular, hemo-
dynamic, and white matter changes in an overlapping sub-
set of sham controls and LPS-treated animals [17]. All
procedures were approved by the Animal Ethics Commit-
tee of the University of Auckland. In brief, 35 time-mated
Romney–Suffolk-cross fetal sheep were instrumented using
sterile technique at 97 to 98 days ga (full term is 145 days).
Food but not water was withdrawn 18 hours before
surgery. Ewes were given 1 mL/10 kg oxytetracycline
(200 mg/mL, Phoenix Pharm Distributors Ltd., Auckland,
New Zealand) intramuscularly for prophylaxis 30 minutes
before the start of surgery. Ewes were anesthetized by anintravenous injection of propofol (5 mg/kg, AstraZeneca
Limited, Auckland, New Zealand), followed by between 2
and 3% isoflurane in oxygen. The depth of anesthesia and
maternal respiration were constantly monitored by trained
anesthetic staff. Ewes received a constant infusion of an
isotonic saline drip (at an infusion rate of approximately
250 mL/h) to maintain fluid balance.
Following a maternal midline abdominal incision and
exteriorization of the fetus from the uterus, a femoral
and brachial artery and a brachial vein were catheterized
with polyvinyl catheters to allow for mean arterial blood
pressure monitoring and preductal blood sampling and
infusions. An amniotic catheter was secured to the fetal
shoulder. Electrocardiogram (ECG) electrodes (Cooner
Wire Co., Chatsworth, California, United States) were
sewn across the fetal chest to record fetal heart rate. An
inflatable silicon occluder was placed around the um-
bilical cord (In Vivo Metric, Healdsburg, California,
United States). The uterus was then closed. Antibiotics
(80 mg gentamicin, Pharmacia and Upjohn, Rydalmere,
New South Wales, Australia) were administered into the
amniotic sac. The maternal laparotomy skin incision was
infiltrated with 10 mL of a local analgesic containing
0.5% bupivacaine plus adrenaline (AstraZeneca Ltd.,
Auckland, New Zealand). All fetal catheters and leads
were exteriorized through the maternal flank. The ma-
ternal long saphenous vein was catheterized for post-
operative maternal care and euthanasia.Postoperative care
Sheep were housed together in separate metabolic cages
with access to food and water ad libitum. They were
kept in a temperature-controlled room (16 ± 1°C, humi-
dity 50 ± 10%), in a 12 hour light/dark cycle. Antibiotics
were intravenously given daily for four days to the ewe
(600 mg benzylpenicillin, Novartis Ltd, Auckland, New
Zealand, and 80 mg gentamicin, Pharmacia and Upjohn).
Fetal catheters were continuously infused with hepa-
rinized saline (20 U/mL at 0.15 mL/hour) and the ma-
ternal catheter was maintained by daily flushing.Experimental design
Experiments started five days after surgery at 102 ± 0 days
of gestational age. Fetuses were randomized into four ex-
perimental groups: (1) Chronic saline infusion and saline
boluses plus sham asphyxia (Sal-Sham; n = 9). (2) Chronic
LPS infusion plus three LPS boluses plus sham asphyxia
(LPS-Sham; n = 9). (3) Chronic saline infusion and saline
boluses plus asphyxia for 15 minutes (Sal-Asp; n = 9).
(4) Chronic LPS infusion plus three LPS boluses plus
asphyxia (LPS-Asp; n = 8). LPS was dissolved in saline
and infused at a rate of 100 ng/24 hours for the first
24 hours, then increased to 250 ng/24 hours for the next
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48, 72, and 96 hours after the start of infusions.
Asphyxia was induced by rapid inflation of the silicon
occluder for 15 minutes with a volume of saline known
to completely occlude the umbilical cord, four hours
after the third saline or LPS bolus. Successful occlusion
was confirmed by the rapid onset of bradycardia and by
subsequent changes in pH and blood gases [21,22].
Fetal arterial blood samples were collected daily, star-
ting from 24 hours before the start of the saline or LPS
infusions, plus 6 hours after each bolus of LPS or saline.
During umbilical cord occlusion, fetal arterial blood was
additionally taken at 5 and 12 minutes during occlusion
and 10 minutes and two hours after occlusion. Blood
samples were analyzed for pH, blood gases (845 Blood
Gas Analyzer/Co-oximeter, Ciba-corning Diagnostics,
Massachusetts, United States), and glucose and lactate
measurements (YSI 2300, Yellow Springs Instruments,
Yellow Springs, Ohio, United States). Additional plasma
was collected for cytokine and cortisol measurements.
Fetal cytokine measurements
Cytokine levels in the plasma were measured using in-
house enzyme-linked immunosorbent assays [17]. Inter-
leukin (IL)-6 was detected using antibodies specific to
ovine IL-6 (Epitope Technologies, Melbourne, Australia).
Standards were ovine recombinant IL-6 (Protein Express,
Cincinnati, Ohio, United States). The standard series
ranged from between 0 and 5 ng/mL. The assay sensitivity
was 0.097 ng/mL and internal quality controls were in-
cluded in each assay. Cytokine concentrations were within
the detection limit in all samples. IL-10 was detected using
antibodies specific to the bovine species (AbD Serotec,
Oxford, United Kingdom) [17]. Standards used were
recombinant bovine IL-10 (kindly supplied by Professor
G Entrican, Moredun Research Institute, Scotland) and
ranged between 0 and 11 BU/mL with a detection sensi-
tivity of 0.086 BU/mL.
Fetal cortisol
Fetal plasma cortisol levels were measured using triple
quadrupole mass spectrometry [17]. A total of 100 μL
of internal standard (20 ng/mL cortisol-d4 in water)
was added to 200 μL plasma. Steroids were extracted
using 1 mL of ethyl acetate (Merck KGaA, Darnstadt,
Germany). After removal of the organic supernatant,
samples were dried by vacuum concentration (Savant
SC250EXP, Thermo Scientific, Asheville, North Carolina,
United States), re-suspended in 60 μL of mobile phase
72% methanol (Merck KGaA) and 28% water, and trans-
ferred to HPLC injector vials. A total of 12 μL was
injected onto an HPLC mass spectrometer system consis-
ting of an Accela MS pump and autosampler followed by
an Ion Max APCI source on a Finnigan TSQ QuantumUltra AM triple quadrupole mass spectrometer, all con-
trolled by Finnigan Xcaliber software (Thermo Electron
Corporation, San Jose, California, United States). The
mobile phase was isocratic, flowing at 250 μL/min
through a Luna HST 2.6 μm C18 (2) 100 × 3.0 mm co-
lumn at 40°C (Phenomenex, Auckland, New Zealand).
Retention time was 3.1 minutes for both cortisol and
cortisol-d4. Ionization was in positive mode and Q2 had
1.2 mTorr of argon. The mass transitions followed were:
cortisol-d4 367.2 – 121.2 at 28 V and cortisol 363.2 –
122.2 at 28 V. Mean inter- and intra-assay coefficient of
variation values for cortisol were 5.8 and 6.0% respectively.
Postmortem and tissue preparation
Ewes were euthanized after day 10 with maternal intra-
venous sodium pentobarbitone (9 g, Pentobarb 300,
Chemstock International, Christchurch, New Zealand).
Fetuses were quickly removed from the uterus and their
brains were perfusion fixed in situ with 500 mL saline,
followed by 4% neutral buffered formalin infused by
gravity feed, and post fixed in formalin for one week
before processing and paraffin embedding. Coronal sections
measuring 10 μm were cut at the level of mid striatum
(approximately 17 mm anterior to stereotaxic zero, shown
in Figure 1) and hippocampus (approximately 26 mm an-
terior to stereotaxic zero) [23] for immunohistochemistry.
Immunohistochemistry
Deparaffinized and rehydrated sections were antigen-
retrieved in a citrate buffer (pH 6.0) for 20 minutes
using a pressure cooker method (2100 Retriever, Prestige
Medical Ltd; Blackburn, United Kingdom). Phosphate-
buffered saline (PBS) washed sections were then treated
with 1% hydrogen peroxide in methanol for 30 minutes
in the dark for quenching endogenous peroxidase acti-
vity. Blocking was done with 3% goat/horse serum in
PBS for one hour at room temperature. Primary and se-
condary antibodies were diluted in 3% goat/horse serum
in PBS. Sections were incubated with primary antibodies
at 4°C overnight for immunohistochemical labeling.
Reactive microglia were labelled with 1:200 goat anti-
ionized calcium-binding adapter molecule-1 antibody
(Iba-1, Sapphire Bioscience Ltd., Auckland, New Zealand).
Cells expressing inflammatory cytokines were labelled
with 1:200 monoclonal mouse anti-tumor necrosis factor-
α (TNF-α) (Abacus ALS, Auckland, New Zealand). Re-
active astrocytes were labelled with 1:500 mouse anti-glial
fibrillary acidic protein (GFAP) (Chemicon International
Inc., Temecula, California, United States). Cells un-
dergoing apoptosis were labelled with 1:200 rabbit anti-
caspase-3 ASP175 (Cell Signaling Technology, Danvers,
Massachusetts, United States). Immature and mature oli-
godendrocytes were labelled with 1:200 mouse mono-
clonal anti-2′, 3′-cyclic nucleotide 3′-phosphodiesterase
Figure 1 Photomicrographs of coronal sections of fetal sheep
brain showing the white matter regions analyzed in this study.
1) periventricular white matter, 2) intragyral white matter. Scale
bar = 2.5 mm.
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oligodendrocyte transcription factor-2 (Olig2) (Merck-
Millipore, Manukau City, New Zealand) in a dilution of
1:200 was used as a marker of all cells in the oligodendro-
cyte lineage [24]. After overnight incubation with corre-
sponding secondary antibodies (1:200) at 4°C, followed by
1:200 ExtrAvidin (Sigma-Aldrich Ltd., Auckland, New
Zealand) at room temperature for three hours, sections
were treated with SIGMAFAST™ 3,3′ diaminobenzidine
(Sigma-Aldrich Ltd.) to visualize immunoreactivity and
mounted with di-n-butyl phthalate in xylene (Sigma-
Aldrich Ltd.). Negative controls were run in parallel.
Assessment of brain injury
Inflammatory responses, CNPase, and Olig2-positive oligo-
dendrocytes and apoptotic cells were quantified in the
periventricular white matter (PVWM) and intragyral white
matter (IGWM) of the first parasagittal gyrus by in-
vestigators blinded to the study groups. The area of micro-
glia infiltration and cell counts were measured by light
microscopy with a Nikon 80i light microscope (Scitech
Ltd., Preston, Victoria, Australia), using StereoInvestigatorsoftware (v10, Microbrightfield Bioscience (MBF), Williston,
Vermont, United States).
Sampling was undertaken using stereological princi-
ples by tracing the contour of the region of interest and
then randomly translating a grid on the image and ap-
plying a fractionator probe with a counting frame for ob-
ject exclusion or inclusion at 40 ×magnification. A total
of 30 sites were screened per slide (counting frame size
100 × 100 μm) and all the estimated cell counts were
converted to cell density (cells/mm2) by the equation:
estimated total counts by fractionator divided by contour
area (μm2) × 106. In the case of cells undergoing apop-
tosis, manual counting was done using the entire region.
Values for the left and right hemispheres and for the two
histological levels per animal were averaged.
Data analysis and statistics
Data were compared between groups using ANOVA
followed by the least significant difference test post hoc
tests when a significant effect of group was found (SPSS
v22, SPSS Inc., Chicago, Illinois, United States). For ana-
lysis of immunohistochemical findings, region was treated
as a repeated measure. Statistical significance was accepted
at P <0.05. Data are mean ± standard error of the mean
(SEM).
Results
There was no mortality in any of the experimental groups.
The LPS-Asp group had lower body weights than the
other groups: Sal-Sham 2.10 ± 0.09 kg, LPS-Sham 2.27 ±
0.09 kg, and Sal-Asp 2.22 ± 0.10 kg versus LPS-Asp 1.82 ±
0.08 kg (P <0.01). There was no significant difference in
brain weight between any of the groups: Sal-Sham 29.7 ±
2.3 g. LPS-Sham 27.2 ± 1.1 g, Sal-Asp 30.4 ± 1.4 g, and
LPS-Asp 28.2 ± 2.0 g.
Fetal blood composition
There were no significant differences in baseline pH,
blood gas, glucose, or lactate measurements between
groups (Table 1). Chronic LPS infusion was not asso-
ciated with any significant differences between groups,
except for an increase in glucose in the Sal-Sham group
on day two (P <0.05). The first LPS bolus was associated
with a significant reduction in glucose in both LPS-
exposed groups compared to both the Sal-Sham and
Sal-Asp groups (P <0.05). The second LPS bolus was
associated with a significant increase in lactate in the
LPS-Sham group compared to the Sal-Sham group fol-
lowing the third bolus and period of asphyxia (P <0.05).
There was a significant increase in lactate in both
asphyxia groups and a significant increase in glucose in
the Sal-Asp group compared to Sal-Sham (Table 2,
P <0.05). All changes had resolved by day six.
Table 1 Arterial pH, blood gases, glucose, and lactate levels
Group -24 h Day 1 Day 1 + 6 h Day 2 Day 3 Day 3 + 6 h Day 4 + 6 h Day 5 + 6 h Day 6
pH S-S 7.38 ± 0.00 7.37 ± 0.01 7.37 ± 0.00 7.36 ± 0.00 7.36 ± 0.01 7.36 ± 0.00 7.35 ± 0.01 7.35 ± 0.01 7.35 ± 0.01
L-S 7.38 ± 0.00 7.38 ± 0.00 7.38 ± 0.00 7.38 ± 0.00 7.38 ± 0.00 7.34 ± 0.00 7.36 ± 0.00 7.36 ± 0.00 7.35 ± 0.00
S-A 7.36 ± 0.00 7.37 ± 0.00 7.36 ± 0.00 7.37 ± 0.00 7.36 ± 0.00 7.37 ± 0.00 7.36 ± 0.00 7.36 ± 0.01 7.36 ± 0.00
L-A 7.37 ± 0.00 7.37 ± 0.00 7.37 ± 0.00 7.36 ± 0.00 7.36 ± 0.00 7.37 ± 0.00 7.38 ± 0.00*# 7.37 ± 0.00 7.35 ± 0.01
paCO2 (mmHg) S-S 45.4 ± 1.4 49.5 ± 0.8 49.6 ± 1.1 50.1 ± 1.0 50.1 ± 1.5 48.3 ± 1.1 49.3 ± 1.2 50.0 ± 2.0 48.3 ± 1.4
L-S 43.9 ± 1.6 49.2 ± 1.6 48.7 ± 1.0 49.2 ± 1.5 48.9 ± 1.1 54.8 ± 2.1 50.7 ± 1.6 48.5 ± 1.4 49.1 ± 1.1
S-A 43.5 ± 1.5 46.5 ± 1.2 47.7 ± 1.0 50.0 ± 1.3 48.5 ± 0.9 49.2 ± 0.8 48.3 ± 1.0 46.0 ± 1.0 47.8 ± 1.7
L-A 42.6 ± 1.1 46.6 ± 1.3 46.2 ± 1.6 48.0 ± 1.7 48.2 ± 1.5 49.3 ± 1.8 46.5 ± 1.2# 43.9 ± 1.6*# 47.4 ± 1.5
paO2 (mmHg) S-S 24.6 ± 1.2 25.2 ± 1.5 24.0 ± 1.6 24.6 ± 2.3 26.3 ± 2.4 23.2 ± 2.9 24.3 ± 3.2 24.7 ± 2.6 25.3 ± 2.3
L-S 26.4 ± 1.2 26.0 ± 1.7 25.4 ± 1.4 25.9 ± 1.7 25.0 ± 2.0 21.4 ± 1.6 24.2 ± 2.7 25.9 ± 2.5 24.7 ± 1.9
S-A 25.6 ± 0.8 24.9 ± 1.5 24.7 ± 1.3 24.3 ± 1.5 24.1 ± 1.7 24.3 ± 1.8 24.3 ± 1.4 26.2 ± 1.3 25.3 ± 1.1
L-A 27.2 ± 0.8 25.4 ± 0.7 24.6 ± 1.0 26.2 ± 0.9 25.3 ± 0.8 22.6 ± 0.8 21.3 ± 1.3 24.2 ± 1.30 27.6 ± 1.6
Lactate (mmol/L) S-S 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.0 0.8 ± 0.06 0.81 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.1
L-S 0.7 ± 0.1 0.7 ± 0.1 0.7 ± 0.0 0.7 ± 0.0 0.8 ± 0.08 1.50 ± 0.2 1.5 ± 0.4* 0.7 ± 0.0 0.6 ± 0.1
S-A 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.13 1.1 ± 0.16 0.9 ± 0.1# 2.2 ± 0.4*# 0.8 ± 0.1
L-A 0.6 ± 0.1 0.6 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 0.7 ± 0.05 1.1 ± 0.31 0.8 ± 0.1 1.8 ± 0.4# 0.7 ± 0.1
Glucose (mmol/L) S-S 0.8 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1
L-S 0.8 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 1.0 ± 0.1* 1.1 ± 0.1 0.9 ± 0.1* 1.0 ± 0.1 1.0 ± 0.1 0.9 ± 0.1
S-A 1.0 ± 0.1 0.9 ± 0.1 1.2 ± 0.1 1.1 ± 0.1* 1.1 ± 0.0 1.3 ± 0.1# 1.2 ± 0.1 1.5 ± 0.1* 1.0 ± 0.1
L-A 0.8 ± 0.1 1.0 ± 0.2 0.9 ± 0.1 1.1 ± 0.1* 1.1 ± 0.1 0.8 ± 0.1*§ 1.0 ± 0.1 1.2 ± 0.1 1.1 ± 0.1
S-S = Sal-Sham (saline infusion + saline boluses + sham occlusion); L-S = LPS-Sham (LPS infusion + LPS boluses + sham occlusion); S-A = Sal-Asp (saline infusion +
saline boluses + 15 minutes of umbilical cord occlusion); L-A = LPS-Asp (LPS infusion + LPS boluses + 15 minutes of umbilical cord occlusion). Saline or LPS infusions
were started on day 1; boluses of saline or LPS were given on days 3, 4 and 5. Data during and after umbilical cord occlusion performed on day 5, 4 hours after
the last LPS or saline bolus, are shown in Table 2. The chronic low-dose LPS or saline infusion continued from time zero to the end of day 5. Days 7 to 10 are not
shown as there were no differences between groups at those times. LPS, lipopolysaccharide; paCO2, fetal arterial pressure of CO2 (mmHg); paO2, fetal arterial
pressure of oxygen (mmHg). * P <0.05 versus Sal-Sham, # P <0.05 versus LPS-Sham, § P <0.05 versus Sal-Asp. Data are mean ± SEM.
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LPS-Sham treatment was associated with a significant
reduction in the number of CNPase positive oligoden-
drocytes in the PVWM and IGWM (P <0.05, Figures 2
and 3). Sal-Asp was associated with a significant overall
loss of CNPase positive oligodendrocytes compared toTable 2 Arterial pH, blood gases, lactate, and glucose values
Group Baseline 5 min
pH S-A 7.35 ± 0.00 7.02 ±
L-A 7.36 ± 0.00 6.98 ±
paCO2 (mmHg) S-A 48 ± 1.1 90.2 ±
L-A 47.6 ± 1.2 95.7 ±
paO2 (mmHg) S-A 24.6 ± 0.8 8.5 ± 0
L-A 24.8 ± 0.8 7.1 ± 0
Lactate (mmol/L) S-A 0.87 ± 0.1 3.4 ± 0
L-A 0.55 ± 0.1 3.3 ± 0
Glucose (mmol/L) S-A 1.1 ± 0.0 0.4 ± 0
L-A 0.9 ± 0.1 0.4 ± 0
Post values are times after umbilical cord occlusion. S-A = Sal-Asp (saline infusion +
(LPS infusion + LPS boluses + 15 minutes of umbilical cord occlusion, n = 8). LPS, lip
arterial pressure of oxygen (mmHg). § P <0.05 versus Sal-Asp. Data are mean ± SEMSal-Sham; post hoc tests suggested that there was a signifi-
cant reduction in the IGWM (P <0.05), but not in the
PVWM. Morphologically, many CNPase positive oligo-
dendrocytes in the LPS-Sham and Sal-Asp groups showed
a reduction in the number of processes and axonal con-
tacts (Figure 3). In contrast, the LPS-Asp group was notbefore during and after umbilical cord occlusion
12 min 10 min post 2 h post
0.01 6.92 ± 0.00 7.21 ± 0.00 7.36 ± 0.00
0.01§ 6.90 ± 0.00 7.22 ± 0.00 7.36 ± 0.00
2.9 111.4 ± 3.1 45.3 ± 0.3 46.5 ± 0.8
4.7 108.6 ± 6.5 46.4 ± 1.4 49.2 ± 0.9
.9 8.1 ± 1.1 34.6 ± 1.3 25.1 ± 0.8
.4 9.4 ± 0.6 33.1 ± 1.0 25 ± 0.9
.2 4.6 ± 0.3 4.3 ± 0.5 1.2 ± 0.3
.4 3.9 ± 0.7 4.7 ± 0.2 0.8 ± 0.1
.1 0.9 ± 0.1 1.7 ± 0.2 1.2 ± 0.1
.1 0.5 ± 0.1 1.6 ± 0.1 1.0 ± 0.1
saline boluses + 15 minutes of umbilical cord occlusion, n = 9); L-A = LPS-Sham
opolysaccharide; paCO2, fetal arterial pressure of CO2 (mmHg); paO2, fetal
.
Figure 2 Changes in numbers of immunohistochemically labeled white matter cells. Bar graphs showing numbers of CNPase positive cells
in the PVWM (A) and IGWM (B), Olig2 positive cells in the PVWM (C) and IGWM (D), Iba-1 positive cells (E) and GFAP positive cells in the PVWM
(F), TNF-α positive cells in the PVWM, (G) and caspase-3 positive cells in the PVWM (H). *P <0.05, **P <0.01, ***P <0.001 versus Sal-Sham controls,
# P <0.05 versus LPS-Sham, § P <0.05 versus Sal-Asp. Data are mean ± SEM. Asp, asphyxia; CNPase, 2′,-3′-Cyclic-nuceotide 3′-phosphodiesterase;
GFAP, glial fibrillary acidic protein; Iba-1, ionized calcium-binding adapter molecule-1; IGWM, intragyral white matter; LPS, lipopolysaccharide;
Olig2, Oligodendrocyte transcription factor-2; PVWM, periventricular white matter; TNF-α, tumor necrosis factor-α; Sal, saline.
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more CNPase positive oligodendrocytes than LPS-Sham
in both regions overall (P <0.01).
LPS-Sham was associated with a significant reduction in
the numbers of Olig2 positive oligodendrocytes in the
IGWM (P <0.05 versus Sal-Sham, Figures 2 and 3) but not
in the PVWM. Sal-Asp and LPS-Asp were associated with
a significant increase in Olig2 positive oligodendrocytes
compared to Sal-Sham (P <0.05). Further, both Sal-Asp
(P <0.05) and LPS-Asp (P <0.01) were associated withincreased numbers of Olig2 positive oligodendrocytes
compared to LPS-Sham.
Apoptotic cell death in PVWM
There was a significant increase in the number of
activated caspase-3 positive apoptotic cells in the
PVWM in the LPS-Sham group compared to Sal-Sham
(P <0.01, Figures 2 and 3). Sal-Asp was associated with
greater numbers of caspase-3 positive cells than all
other groups (P <0.001). In contrast, the LPS-Asp
Figure 3 Photomicrographs of immature and mature oligodendrocytes and caspase-3 labeled apoptotic cells in the PVWM.
Photomicrographs showing CNPase immunolabeling (A-D), and cleaved caspase-3 (ASP175) immunolabeling (E-H) in the PVWM in Sal-Sham
(row 1; A, E), LPS-Sham (row 2; B, F), Sal-Asp (row 3; C, G) and LPS-Asp (bottom; D, H). Arrows show examples of labeled cells. Note the reduction
in CNPase positive cells and increase in activated caspase-3 labelling after LPS-Sham and Sal-Asp. Surviving CNPase positive cells show stunted
processes. LPS-Asp treatment was associated with recovery of CNPase positive immature and mature oligodendrocytes to Sal-Sham values, and
reduced numbers of activated caspase-3 positive cells compared with Sal-Asp but not LPS-Sham. Scale bar = 20 μm. Asp, asphyxia; CNPase,
2′,-3′-Cyclic-nuceotide 3′-phosphodiesterase; LPS, lipopolysaccharide; PVWM, periventricular white matter; Sal, saline.
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cells compared to Sal-Asp, but was similar to the LPS-
Sham group and still increased compared to Sal-Sham.
Iba-1 positive microglia
Ramified microglia were predominantly present in the
PVWM of Sal-Sham controls. LPS treatment and occlu-
sion were independently associated with increased num-
bers of reactive microglia, larger cell bodies and thickerprocesses, and patchy infiltration of the white matter
tracts (Figures 2 and 4). The area of the PVWM showing
reactive microglial infiltration was significantly greater
(P <0.001) in the LPS-Sham, Sal-Asp, and LPS-Asp groups
compared to Sal-Sham (Sal-Sham 1.3 ± 1.2%; LPS-Sham
15.5 ± 1.0%; Sal-Asp 19.6 ± 5.0%, and LPS-Asp 12.9 ±
5.8%). Consistent with this, LPS-Sham and Sal-Asp were
both associated with a significant increase in the numbers
of microglia in the PVWM compared to Sal-Sham
Figure 4 Photomicrographs showing astrocytes, microglia and TNF-α labeled cells in the PVWM. Photomicrographs showing glial fibrillary
acidic protein (GFAP) (First column; A-D), Iba-1 (Second column; E-H), and tumor necrosis factor (TNF)-α immunolabeling (Third column; I-L) in
the PVWM in Sal-Sham (row 1; A, E, I), LPS-Sham (row 2; B, F, J), Sal-Asp (row 3; C, G, K) and LPS-Asp (bottom; D, H, L). Arrows show
examples of labeled cells. Note the robust induction of Iba-1 positive reactive microglia and GFAP positive reactive astrocytes after LPS-Sham
treatment and Sal-Asp treatment, which was significantly attenuated in the LPS-Asp group. The LPS-Asp group showed astrocytes with thinner
bodies and fewer processes than LPS-Sham and Sal-Asp. Scale bar = 20 μm. Asp, asphyxia; GFAP, glial fibrillary acidic protein; Iba-1, ionized
calcium-binding adapter molecule-1; LPS, lipopolysaccharide; PVWM, periventricular white matter; Sal, saline; TNF-α: tumor necrosis factor-α.
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duced microglial induction compared to LPS-Sham and
Sal-Asp (P < 0.001, Figures 2 and 4).
Astroglial responses in the PVWM
LPS-Sham and Sal-Asp were associated with increased
astrogliosis compared to Sal-Sham (P <0.01, Figures 2
and 4). In contrast, there was a significant reduction in
reactive astrocytes in the LPS-Asp group compared to
LPS-Sham and Sal-Asp (P <0.05).
Induction of TNF-α
LPS-Sham and Sal-Asp were both associated with a signifi-
cant increase in the number of cells expressing TNF-α in
the PVWM (P <0.001, Figures 2 and 4) compared to Sal-
Sham. The number of TNF-α positive cells was reduced in
the LPS-Asp group compared to Sal-Asp (P <0.001).
Cytokine and cortisol analysis
Low-dose, chronic LPS administration was associated with
a transient increase in IL-10 in the LPS-Sham groupcompared to the Sal-Sham group (P <0.05, Figure 5). The
first LPS bolus was associated with a significant increase
in IL-6 in the LPS-Sham group compared to all other
groups (P <0.05) and an apparent trend towards an
increase in the LPS-Asp group compared to Sal-Asp
(P = 0.09). A significant increase in IL-10 was seen in the
LPS-Asp group compared to Sal-Sham and Sal-Asp, and
in the LPS-Sham group compared to the Sal-Sham and
Sal-Asp groups (P <0.05). The first bolus was also asso-
ciated with a significant increase in cortisol levels in the
LPS-Sham group and a significantly greater increase in
the LPS-Asp groups compared to Sal-Sham (P <0.05). A
similar increase in cortisol was seen after the second and
third LPS boluses. A significant increase in cortisol was
seen following asphyxia in the LPS-Asp group compared to
all other groups. There were no further significant changes
in IL-6 or IL-10 after the second and third bolus, other than
a significant increase in IL-10 in the LPS-Asp group com-
pared to Sal-Asp after the third bolus, prior to the onset of
asphyxia (P <0.05). There were no differences between the
Sal-Sham and Sal-Asp groups at any time point.
Figure 5 Time sequence of changes in fetal plasma IL-6, IL-10
and cortisol concentrations. The horizontal bars at the top of the
figure show the chronic infusions of LPS or saline. The arrows represent
the times of the three LPS bolus doses (B1, B2 and B3). The vertical
dashed line shows the time of the 15 minute period of umbilical cord
occlusion in the asphyxia groups. Data were not available in the
LPS-Sham group for the 11 am time point on day five. Data are mean ±
SEM. *P <0.05. A) Sal-Sham versus LPS-Sham; B) Sal-Sham versus LPS-Asp;
C) LPS-Sham versus Sal-Asp; D) LPS-Sham versus LPS-Asp; E) Sal-Asp
versus LPS-Asp. Asp, asphyxia; IL, interleukin; LPS, lipopolysaccharide; Sal,
saline.
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This study has demonstrated that acute-on-chronic LPS
administration conditioned the preterm fetal sheep brain
to reduce white matter injury from subsequent asphyxia.
Intriguingly, this study also showed for the first time that
asphyxia also conditioned the brain to reduce brain injury
from preceding LPS exposure. Acute-on-chronic LPS
administration was associated with significant loss of im-
mature and mature oligodendrocytes and marked neuro-
inflammation and astrogliosis [17]. Complete umbilical
cord occlusion for 15 minutes was associated with mild
injury, including loss of immature and mature oligoden-
drocytes in the intragyral white matter and increased in-
flammation and astrogliosis. In contrast, animals exposed
to both LPS and asphyxia showed marked attenuation of
white matter inflammation and astrogliosis, with im-
proved survival of immature and mature oligodendrocytes
in the white matter compared to LPS exposure or as-
phyxia alone.
The present findings add to the evidence that there is
substantial crossover in the mechanisms of infection and
hypoxia-ischemia-related brain injury [25]. In contrast
with studies of single acute doses of LPS that typically sug-
gest that prior exposure to LPS increases the severity of
later HI injury, the present study suggests a protective
effect. The most likely reason for this difference is that
continued exposure to LPS induced both self-tolerance
and cross-tolerance, as found in both the whole animal
[25] and even in isolated monocytes after chronic or re-
peated exposure to endotoxin in vitro [26,27]. This dif-
ference from previous neonatal studies is unlikely to
reflect earlier exposure alone, since Eklind et al. [9] found
marked sensitization when HI was induced 72 hours after
exposure to LPS. Further, the present study used umbilical
cord occlusion to induce asphyxia, with profound hypoxia,
metabolic acidosis and hypotension, rather than carotid
ligation with moderate hypoxia as used in neonatal rat
studies. Nevertheless, adult rat studies have reported pre-
conditioning with LPS before focal or global ischemia
[25]. Finally, although we cannot rule out species dif-
ferences, studies in adult rodents also suggest that LPS
can protect against subsequent ischemic insults induced
48 hours or more after LPS [25].
Both acute-on-chronic LPS and asphyxia were asso-
ciated with an overall loss of immature and mature
(CNPase positive) oligodendrocytes in the white matter
tracts, while LPS but not asphyxia was also associated with
an overall reduction in total numbers of (Olig2 positive)
oligodendrocytes. Further, both LPS and asphyxia were as-
sociated with a similar induction of microglia and astro-
gliosis. However, when combined as in the present study,
LPS and asphyxia were associated with mutual protection,
with significantly more immature and mature oligoden-
drocytes and reduced inflammation and astrogliosis,
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This combination of greater total numbers of oligoden-
drocytes after asphyxia with the reduction in immature and
mature oligodendrocytes in the present study denotes a
relative increase in numbers of pre-oligodendrocytes in the
white matter tracts. The oligodendroglia proliferative re-
sponse to injury is almost entirely mediated by progenitor
cells [28]. Thus, these data suggest reduced maturation into
mature oligodendrocytes combined with significant prolif-
eration of new pre-oligodendrocytes. This is consistent with
data in the neonatal rat and the preterm fetal sheep that
showed initial degeneration of pre-oligodendrocytes, that
was offset by proliferation of pre-oligodendrocytes which,
however, fail to mature after HI [29,30]. Similar evidence
for the maturational arrest of pre-oligodendrocytes is seen
in human neonatal white matter injury at postmortem [2].
In turn, the finding of extensive white matter astro-
gliosis in the present study is consistent with both
clinical and experimental studies [2,29,30] and with
increasing evidence that reactive astrocytes actively
inhibit oligodendrocyte maturation [3]. In the present
study the combination of asphyxia and inflammation
was unexpectedly associated with restoration of the
immature and mature oligodendrocytes to near-saline-
sham values, with increased total oligodendrocyte
number. The finding of reduced microglial induction
and astrogliosis suggests that LPS pre-exposure re-
duced asphyxia-induced loss of pre-oligodendrocytes
and that the combination attenuated the overall in-
flammatory reaction that was seen after both asphyxia
and inflammation alone. Further longterm studies will
be important to determine whether this arrest of mat-
uration after five days recovery from asphyxia and the
apparent improvement with LPS pre-exposure in the
present study are persistent.
Although many mechanisms have been implicated in
both tolerance and sensitization between infection and/
or inflammation and HI, as seen in the present study,
both asphyxia and inflammation are associated with a
marked inflammatory response. The toll-like receptors
that mediate innate immune responses can also sense
cell damage after ischemia, and are present on neural
microglia, oligodendrocytes, and neurons, as recently
reviewed [25]. Self-induced tolerance to LPS is well rec-
ognized in many settings, and likely contributes to the
greater cardiovascular tolerance and survival to high-
dose LPS after chronic low-dose exposure as previously
reported [17]. Alternatively, there is evidence that LPS
can upregulate anti-inflammatory interferons in adult
rodents [31].
The most intriguing aspect of this study is that protec-
tion against LPS-associated brain injury was seen when
asphyxia was induced after the fetuses had receivedthree high-dose boluses of LPS, although before the end
of the chronic low-dose infusion. This striking finding
denotes that much of the LPS-induced damage evolved
over the six days after the last high-dose bolus. There is
evidence for such postconditioning in other settings. For
example, in adult mice, mild cerebral ischemia induced
immediately, two minutes, or three hours after severe
middle cerebral artery occlusion was shown to be neuro-
protective and associated with reduced inflammation
[32]. Postconditioning has also been shown to be neuro-
protective in rodent models of global cerebral ischemia,
both in terms of a reduction in behavioral deficits and
neuronal death in the hippocampus and parietal cortex
[33]. Previous experiments in rodent models suggest that
the combination of preconditioning and postconditio-
ning offers no synergistic protection, likely due to over-
lapping mechanisms of action [34,35]. However, in these
studies, pre- and postconditioning were both induced by
ischemia. In the current study, the synergistic neuropro-
tection may suggest different mechanisms of action for
LPS-induced pre conditioning and ischemia postcondi-
tioning [36].
Alternatively, it is possible that counter-regulatory re-
sponses may have contributed in part to conditioning.
Neuroprotection with LPS administration 24 hours before
HI in seven-day-old rats was associated with upregulation
of corticosterone and changes in gene expression, particu-
larly those related to immune and inflammatory processes
[37]. In the current study there was a significant increase
in plasma cortisol levels after asphyxia in the LPS-Asp
group, which may have contributed to pre conditioning.
Further, we observed an increase in the anti-inflammatory
cytokine IL-10 before asphyxia. IL-10 can reduce hypoxia-
induced hyperexcitability in hippocampal slice neurons
[38], and is an essential mediator of astroglial pre-
conditioning to mild oxidative stress in culture [39].
Sevoflurane-induced postconditioning of global cerebral
ischemia in adult rats is associated with suppression of
pro-inflammatory cytokines and increased IL-10 [40].
Similarly, global cerebral ischemia in adult rats was associ-
ated with increased pro-inflammatory cytokines and de-
creased IL-10, which was reversed by mild ischemic
preconditioning [41]. Thus, it is possible that the combin-
ation of greater cortisol and anti-inflammatory cytokines
may have contributed in part to the decreased microglial
and astrocyte activation seen with the combination of LPS
and asphyxia compared to either LPS or asphyxia alone.
In conclusion, this study highlights a novel phenomenon
of synergistic neuronal and white matter protection with
LPS-preconditioning and ischemic postconditioning in
preterm fetal sheep. Although exposure to infection and/
or inflammation is associated with adverse outcomes, it
may be relevant that prophylactic maternal antibiotics be-
fore preterm labor with intact membranes not only do not
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they may be associated with increased risk of death and
disability [42]. We speculate that in the context of the very
high risks of neurodevelopmental impairment to which
very preterm infants are exposed, that a little bit of inflam-
mation may even be beneficial. Further studies of how the
nature and timing of infection and/or inflammation
modulate HI injury are needed to help understand their
role in preterm brain injury.
Abbreviations
Asp: asphyxia; CNPase: 2′,-3′-Cyclic-nuceotide 3′-phosphodiesterase; GFAP: Glial
fibrillary acidic protein; HI: Hypoxia-ischemia; Iba-1: Ionized calcium-binding
adapter molecule-1; IGWM: Intragyral white matter; IL: Interleukin;
LPS: Lipopolysaccharide; NO: Nitric oxide; Olig2: Oligodendrocyte transcription
factor-2; PBS: Phosphate-buffered saline; PVWM: Periventricular white matter;
Sal: Saline; TNF-α: Tumor necrosis factor-α.
Competing interests
The authors declare that there are no competing interests.
Authors’ contributions
LB and AJG conceptualized the study. LB, AJG, LGH and JOD designed the
protocol and setup the experimental preparations. LGH, JOD, CAL, LCB
carried out experiments, and histology preparation. MF and CAL analyzed
endocrine samples. LGH and SM analyzed immunohistochemistry. AJG, JOD
and LB provided critical interpretation. LGH, AJG and SM drafted the paper.
All authors contributed to editing the paper and have read and approved
the final version of the manuscript.
Acknowledgements
This work was supported by grants from the Health Research Council of
New Zealand (grants 11-576 and 12-613), the Auckland Medical Research
Foundation (grant 1108004), and Lottery Health Grants trust (grant 209214).
LVH and CAL were the recipients of Auckland Medical Research Foundation
doctoral scholarships.
Author details
1Department of Physiology, University of Auckland, Park Road, Grafton,
Auckland 1023, New Zealand. 2The Liggins Institute, University of Auckland,
Park Road, Grafton, Auckland 1023, New Zealand.
Received: 15 March 2014 Accepted: 1 May 2014
Published: 16 May 2014
References
1. Committee on Understanding Premature Birth and Assuring Healthy
Outcomes: In Preterm Birth: Causes, Consequences, and Prevention. Edited by
Behrman RE, Butler AS. Institute of Medicine, The National Academies Press:
Washington, D.C; 2007. http://books.nap.edu//catalog/11622.html#toc.
2. Buser JR, Maire J, Riddle A, Gong X, Nguyen T, Nelson K, Luo NL, Ren J,
Struve J, Sherman LS, Miller SP, Chau V, Hendson G, Ballabh P, Grafe MR,
Back SA: Arrested preoligodendrocyte maturation contributes to
myelination failure in premature infants. Ann Neurol 2012, 71:93–109.
3. Dean JM, Bennet L, Back SA, McClendon E, Riddle A, Gunn AJ: What brakes
the preterm brain? An arresting story. Pediatr Res 2014, 75:227–233.
4. Low JA, Killen H, Derrick EJ: Antepartum fetal asphyxia in the preterm
pregnancy. Am J Obstet Gynecol 2003, 188:461–465.
5. Wu YW, Colford JM Jr: Chorioamnionitis as a risk factor for cerebral palsy:
a meta-analysis. JAMA 2000, 284:1417–1424.
6. Grether JK, Nelson KB: Maternal infection and cerebral palsy in infants of
normal birth weight. JAMA 1997, 278:207–211.
7. Wikstrom S, Ley D, Hansen-Pupp I, Rosen I, Hellstrom-Westas L: Early
amplitude-integrated EEG correlates with cord TNF-alpha and brain
injury in very preterm infants. Acta Paediatr 2008, 97:915–919.
8. Leviton A, Fichorova RN, O’Shea TM, Kuban K, Paneth N, Dammann O,
Allred EN: Two-hit model of brain damage in the very preterm newborn:
small for gestational age and postnatal systemic inflammation. Pediatr
Res 2013, 73:362–370.9. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I,
Hagberg H: Bacterial endotoxin sensitizes the immature brain to
hypoxic–ischaemic injury. Eur J Neurosci 2001, 13:1101–1106.
10. Yang L, Sameshima H, Ikeda T, Ikenoue T: Lipopolysaccharide
administration enhances hypoxic-ischemic brain damage in newborn
rats. J Obstet Gynaecol Res 2004, 30:142–147.
11. Ikeda T, Mishima K, Aoo N, Egashira N, Iwasaki K, Fujiwara M, Ikenoue T:
Combination treatment of neonatal rats with hypoxia-ischemia and
endotoxin induces long-lasting memory and learning impairment that is
associated with extended cerebral damage. Am J Obstet Gynecol 2004,
191:2132–2141.
12. Eklind S, Mallard C, Arvidsson P, Hagberg H: Lipopolysaccharide induces
both a primary and a secondary phase of sensitization in the developing
rat brain. Pediatr Res 2005, 58:112–116.
13. Wang LW, Chang YC, Lin CY, Hong JS, Huang CC: Low-dose
lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white
matter injury in the immature brain. Pediatr Res 2010, 68:41–47.
14. Lin HY, Huang CC, Chang KF: Lipopolysaccharide preconditioning reduces
neuroinflammation against hypoxic ischemia and provides long-term
outcome of neuroprotection in neonatal rat. Pediatr Res 2009, 66:254–259.
15. Lin WY, Chang YC, Ho CJ, Huang CC: Ischemic preconditioning reduces
neurovascular damage after hypoxia-ischemia via the cellular inhibitor
of apoptosis 1 in neonatal brain. Stroke 2013, 44:162–169.
16. Garnier Y, Coumans A, Berger R, Jensen A, Hasaart TH: Endotoxemia
severely affects circulation during normoxia and asphyxia in immature
fetal sheep. J Soc Gynecol Investig 2001, 8:134–142.
17. Mathai S, Booth LC, Davidson JO, Drury PP, Fraser M, Jensen EC, George S,
Naylor AS, Gunn AJ, Bennet L: Acute on chronic exposure to endotoxin
in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol 2013,
304:R189–R197.
18. Booth LC, Drury PP, Muir C, Jensen E, Gunn AJ, Bennet L: Acute on chronic
exposure to endotoxin is associated with enhanced chemoreflex
responses in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol
2013, 304:R799–R803.
19. Keogh MJ, Drury PP, Bennet L, Davidson JO, Mathai S, Gunn ER, Booth LC,
Gunn AJ: Limited predictive value of early changes in EEG spectral
power for neural injury after asphyxia in preterm fetal sheep. Pediatr Res
2012, 71:345–353.
20. Barlow RM: The foetal sheep: morphogenesis of the nervous system
and histochemical aspects of myelination. J Comp Neurol 1969,
135:249–262.
21. Bennet L, Roelfsema V, Dean J, Wassink G, Power GG, Jensen EC, Gunn AJ:
Regulation of cytochrome oxidase redox state during umbilical cord
occlusion in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol
2007, 292:R1569–R1576.
22. Wassink G, Bennet L, Booth LC, Jensen EC, Wibbens B, Dean JM, Gunn AJ:
The ontogeny of hemodynamic responses to prolonged umbilical cord
occlusion in fetal sheep. J Appl Physiol 2007, 103:1311–1317.
23. Gluckman PD, Parsons Y: Stereotaxic method and atlas for the ovine fetal
forebrain. J Dev Physiol 1983, 5:101–128.
24. Jakovcevski I, Filipovic R, Mo Z, Rakic S, Zecevic N: Oligodendrocyte
development and the onset of myelination in the human fetal brain.
Front Neuroanat 2009, 3:5.
25. Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, Jing Z, Chen J, Zigmond MJ,
Gao Y: Preconditioning provides neuroprotection in models of CNS
disease: Paradigms and clinical significance. Prog Neurobiol 2014,
114C:58–83.
26. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH: Endotoxin-
induced chorioamnionitis modulates innate immunity of monocytes in
preterm sheep. Am J Respir Crit Care Med 2005, 171:73–77.
27. Kallapur SG, Jobe AH, Ball MK, Nitsos I, Moss TJ, Hillman NH, Newnham JP,
Kramer BW: Pulmonary and systemic endotoxin tolerance in preterm
fetal sheep exposed to chorioamnionitis. J Immunol 2007, 179:8491–8499.
28. Baumann N, Pham-Dinh D: Biology of oligodendrocyte and myelin in the
mammalian central nervous system. Physiol Rev 2001, 81:871–927.
29. Segovia KN, McClure M, Moravec M, Luo NL, Wan Y, Gong X, Riddle A,
Craig A, Struve J, Sherman LS, Back SA: Arrested oligodendrocyte lineage
maturation in chronic perinatal white matter injury. Ann Neurol 2008,
63:520–530.
30. Riddle A, Dean J, Buser JR, Gong X, Maire J, Chen K, Ahmad T, Cai V,
Nguyen T, Kroenke CD, Hohimer AR, Back SA: Histopathological correlates
van den Heuij et al. Journal of Neuroinflammation 2014, 11:89 Page 12 of 12
http://www.jneuroinflammation.com/content/11/1/89of magnetic resonance imaging-defined chronic perinatal white matter
injury. Ann Neurol 2011, 70:493–507.
31. Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS,
Stenzel-Poore MP: LPS preconditioning redirects TLR signaling following
stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic
injury. J Neuroinflammation 2011, 8:140.
32. Joo SP, Xie W, Xiong X, Xu B, Zhao H: Ischemic postconditioning protects
against focal cerebral ischemia by inhibiting brain inflammation while
attenuating peripheral lymphopenia in mice. Neuroscience 2013,
243:149–157.
33. Rehni AK, Singh N: Role of phosphoinositide 3-kinase in ischemic
postconditioning-induced attenuation of cerebral ischemia-evoked
behavioral deficits in mice. Pharmacol Rep 2007, 59:192–198.
34. Gao X, Ren C, Zhao H: Protective effects of ischemic postconditioning
compared with gradual reperfusion or preconditioning. J Neurosci Res
2008, 86:2505–2511.
35. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z, Gala R,
Simon RP: In vivo and in vitro characterization of a novel
neuroprotective strategy for stroke: ischemic postconditioning. J Cereb
Blood Flow Metab 2008, 28:232–241.
36. Vartanian K, Stenzel-Poore M: Toll-like receptor tolerance as a mechanism
for neuroprotection. Transl Stroke Res 2010, 1:252–260.
37. Mallard C, Hagberg H: Inflammation-induced preconditioning in the
immature brain. Semin Fetal Neonatal Med 2007, 12:280–286.
38. Burkovetskaya ME, Levin SG, Godukhin OV: Neuroprotective effects of
interleukin-10 and tumor necrosis factor-alpha against hypoxia-induced
hyperexcitability in hippocampal slice neurons. Neurosci Lett 2007,
416:236–240.
39. Segev-Amzaleg N, Trudler D, Frenkel D: Preconditioning to mild oxidative
stress mediates astroglial neuroprotection in an IL-10-dependent
manner. Brain Behav Immun 2013, 30:176–185.
40. Zhang Y, Zhang FG, Meng C, Tian SY, Wang YX, Zhao W, Chen J, Zhang XS,
Liang Y, Zhang SD, Xing YJ: Inhibition of sevoflurane postconditioning
against cerebral ischemia reperfusion-induced oxidative injury in rats.
Molecules 2012, 17:341–354.
41. Nassar NN, Abdelsalam RM, Abdel-Rahman AA, Abdallah DM: Possible
involvement of oxidative stress and inflammatory mediators in the
protective effects of the early preconditioning window against transient
global ischemia in rats. Neurochem Res 2012, 37:614–621.
42. Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N: Prophylactic
antibiotics for inhibiting preterm labour with intact membranes.
Cochrane Database Syst Rev 2013, 12, CD000246.
doi:10.1186/1742-2094-11-89
Cite this article as: van den Heuij et al.: Synergistic white matter
protection with acute-on-chronic endotoxin and subsequent asphyxia
in preterm fetal sheep. Journal of Neuroinflammation 2014 11:89.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
